• RegMed XB

    Regenerative Medicine Crossing Borders

Industrial partners

In order to realize the ambition of RegMed XB to bring solutions to the patients on a large scale the RM products we develop will have to be commercialized. This will ensure large-scale production and efficient production methods to reduce costs. Furthermore, the expertise in the RegMed XB ecosystem can also boost the development of new and existing products from the emerging RM companies. All in all, it is a perfect match to partner up with companies to access their expertise to design scalable and feasible products and together scout for opportunities to valorize new opportunities in the pipeline of the companies or the academic partners. Currently, we have strong partnerships with the following entities.

300MICRONS

300MICRONS

50-80 words

More information
Access2Bone

Access2Bone

Access2Bone is a start-up in the orthopaedic market of bone void fillers. Worldwide the number of bone grafting procedures performed in an ever more geriatric population is growing rapidly. For a growing group of geriatric patients with a compromised bone regeneration metabolism Access2Bone is to create the best bone void filling solutions surgeons need to help these patients best. Access2Bone envisions to lead the high-end segment of bone void fillers by creating highly osteo inductive products that are safe by design and disruptively efficient. Access2Bone’s products are based on naturally derived growth factors. Access2Bone is aiding the Osteoarthritis Moonshot with coating implants that being developed by the Moonshot team with A2B’s growth factors to stimulate fusion between the patient’s bone and the implants being developed.

More information
CytoSMART Technologies

CytoSMART Technologies

50-80 words

More information
FUJIFILM

FUJIFILM

50-80 words

More information
Galapagos

Galapagos

50-80 words

More information
HCM-Medical

HCM-Medical

50-80 words

More information
Kuros Biosciences

Kuros Biosciences

50-80 words

More information
Leiden Regenerative Medicine Platform Holding (Starfish)

Leiden Regenerative Medicine Platform Holding (Starfish)

50-80 words

More information
LifeTec Group

LifeTec Group

50-80 words

More information
Materiomics

Materiomics

50-80 words

More information
Mimetas

Mimetas

50-80 words

More information
Ncardia

Ncardia

50-80 words

More information
Nestegg Biotech

Nestegg Biotech

50-80 words

More information
Ntrans Technologies

Ntrans Technologies

50-80 words

More information
Osteo-Pharma

Osteo-Pharma

Osteo--Pharma is a Life Sciences company that focuses on bone regeneration and is developing innovative medical devices and pharmaceuticals for the orthopedic and dental field. Osteo-Pharma applies its patented, OsteoActivator® technology that enables sustained delivery over multiple weeks of ancillary amounts of bone healing compounds for local treatment of a bone fracture or bone defect. The European Patent Office has recently granted a composition of matter patent covering OsteoActivator® formulations. The Osteo-Pharma portfolio consists of:

  1. OsteoActivator coated collagen membranes with enhanced “guided bone regeneration” characteristics
  2. Spray coated implants e.g. for orthopedic and dental screws
  3. Osteo-Activator microspheres as an injectable formulation designed for intra-osseous bone treatments such as bone marrow lesions (BML) in subchondral bone of osteoarthritis patients or spinal compression fractures by direct injection into the vertebra.

Osteo-pharma has successfully completed pre-clinal studies and is now actively advancing its lead products towards the clinic and market.

More information
Scinus Cell Expansion Netherlands

Scinus Cell Expansion Netherlands

50-80 words

More information
STENTiT

STENTiT

Osteo--Pharma is a Life Sciences company that focuses on bone regeneration and is developing innovative medical devices and pharmaceuticals for the orthopedic and dental field. Osteo-Pharma applies its patented, OsteoActivator® technology that enables sustained delivery over multiple weeks of ancillary amounts of bone healing compounds for local treatment of a bone fracture or bone defect. The European Patent Office has recently granted a composition of matter patent covering OsteoActivator® formulations. The Osteo-Pharma portfolio consists of:

  1. OsteoActivator coated collagen membranes with enhanced “guided bone regeneration” characteristics
  2. Spray coated implants e.g. for orthopedic and dental screws
  3. Osteo-Activator microspheres as an injectable formulation designed for intra-osseous bone treatments such as bone marrow lesions (BML) in subchondral bone of osteoarthritis patients or spinal compression fractures by direct injection into the vertebra.

Osteo-pharma has successfully completed pre-clinal studies and is now actively advancing its lead products towards the clinic and market.

More information
Stichting Chemelot InSciTe

Stichting Chemelot InSciTe

50-80 words

More information
Suprapolix

Suprapolix

50-80 words

More information
Veldlaser

Veldlaser

50-80 words

More information
Visualsonics

Visualsonics

50-80 words

More information
Xeltis

Xeltis

50-80 words

More information
  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2020 RegMed XB. All rights reserved
Realisation & design by Joomlapartner